Xinhong Wu, PhD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer (NCT07130643) | Xinhong Wu, PhD | 2024-12-20 |
| Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer (NCT03716245) | Xinhong Wu, PhD | 2019-02-27 |
Track Xinhong Wu, PhD automatically
Every clearance here is in the API, with alerts when new ones post.